We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$585M
AUM Growth
+$104K
Cap. Flow
-$14.4M
Cap. Flow %
-2.46%
Top 10 Hldgs %
42.57%
Holding
347
New
14
Increased
7
Reduced
65
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.51M
2
LLY icon
Eli Lilly
LLY
+$1.38M
3
TWLO icon
Twilio
TWLO
+$864K
4
TXG icon
10x Genomics
TXG
+$824K
5
BALY icon
Bally's
BALY
+$308K

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$4.77M
2
RTX icon
RTX Corp
RTX
+$1.87M
3
AMAT icon
Applied Materials
AMAT
+$1.01M
4
MSFT icon
Microsoft
MSFT
+$1M
5
AKAM icon
Akamai
AKAM
+$947K

Sector Composition

Rank Sector Weight
1 Technology 31.27%
2 Healthcare 14.59%
3 Consumer Discretionary 14.33%
4 Financials 13.09%
5 Communication Services 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
126
AbbVie
ABBV
$433B
$517K 0.09%
4,777
FIVE icon
127
Five Below
FIVE
$12B
$516K 0.09%
2,702
WING icon
128
Wingstop
WING
$3.55B
$475K 0.08%
3,735
SSD icon
129
Simpson Manufacturing
SSD
$7.91B
$472K 0.08%
4,538
LAD icon
130
Lithia Motors
LAD
$8.31B
$465K 0.08%
1,193
CSCO icon
131
Cisco
CSCO
$457B
$452K 0.08%
8,736
AGYS icon
132
Agilysys
AGYS
$3.09B
$432K 0.07%
9,012
RLI icon
133
RLI Corp
RLI
$5.62B
$428K 0.07%
7,668
ARES icon
134
Ares Management
ARES
$31.3B
$427K 0.07%
7,623
RARE icon
135
Ultragenyx Pharmaceutical
RARE
$2.46B
$407K 0.07%
3,578
JNJ icon
136
Johnson & Johnson
JNJ
$613B
$406K 0.07%
2,471
GSHD icon
137
Goosehead Insurance
GSHD
$2.33B
$405K 0.07%
3,777
PEN icon
138
Penumbra
PEN
$12.7B
$403K 0.07%
1,491
KWR icon
139
Quaker Houghton
KWR
$2.89B
$401K 0.07%
1,647
MCRI icon
140
Monarch Casino & Resort
MCRI
$2.24B
$394K 0.07%
6,506
+2,147
+49% +$131K
RH icon
141
RH
RH
$3.29B
$394K 0.07%
660
VRNS icon
142
Varonis Systems
VRNS
$4.73B
$391K 0.07%
7,614
EVBG
143
DELISTED
Everbridge, Inc. Common Stock
EVBG
$381K 0.07%
3,140
UNP icon
144
Union Pacific
UNP
$173B
$365K 0.06%
1,657
MSA icon
145
Mine Safety
MSA
$7.43B
$355K 0.06%
2,366
TSEM icon
146
Tower Semiconductor
TSEM
$26.5B
$353K 0.06%
12,576
PRLB icon
147
Protolabs
PRLB
$1.91B
$351K 0.06%
2,883
FATE icon
148
Fate Therapeutics
FATE
$291M
$349K 0.06%
4,230
PLNT icon
149
Planet Fitness
PLNT
$4.45B
$347K 0.06%
4,492
RETA
150
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$347K 0.06%
3,483

Similar funds

Silvant Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Silvant Capital Management held 347 positions worth $585M, up 0.02% from $585M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Silvant Capital Management's Q1 2021 filing shows 14 new, 7 increased, 65 reduced and 13 closed positions. Its largest new stake was 10x Genomics: 4,773 shares worth $864K. The largest sale was Home Depot, an estimated $4.77M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Silvant Capital Management's largest Q1 2021 buy was 10x Genomics: 4,773 shares worth $864K.
  • Silvant Capital Management added most to NVIDIA in Q1 2021, an estimated $1.51M increase.
  • Silvant Capital Management's biggest Q1 2021 reduction was Home Depot, cutting an estimated $4.77M.
  • Silvant Capital Management fully exited Akamai in Q1 2021, selling an estimated $947K.
  • Silvant Capital Management's ten largest holdings make up 43% of its $585M portfolio in Q1 2021.
  • Silvant Capital Management opened 14 new positions and closed 13 in Q1 2021.
  • Silvant Capital Management's portfolio value rose 0.02% quarter-over-quarter to $585M.

Based on Silvant Capital Management's 13F filing for Q1 2021, filed 11 May 2021.